Quantcast
Channel: BioTuesdays » Genzyme
Browsing latest articles
Browse All 2 View Live

Image may be NSFW.
Clik here to view.

Top pedigree leading Xcovery’s kinase inhibitors

With two leading biotech entrepreneurs and scientists at the helm, closely held Xcovery Holdings has a leg up as it continues development of next generation kinase inhibitors as treatments for cancer...

View Article



Image may be NSFW.
Clik here to view.

Janney starts Veracyte at buy

Janney Capital Markets has initiated coverage of Veracyte (NASDAQ:VCYT) with a “buy” rating and fair value estimate of $25, saying the company is changing the paradigm of thyroid cancer diagnosis and...

View Article
Browsing latest articles
Browse All 2 View Live




Latest Images